n-pentanol has been researched along with Canine Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäumer, W; Rossbach, K; Schmidt, BH | 1 |
| Hirano, Y; Oosawa, T; Tonosaki, K | 1 |
| Hansen, NH; Szabo, J | 1 |
3 other study(ies) available for n-pentanol and Canine Diseases
| Article | Year |
|---|---|
The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs.
Topics: Administration, Topical; Animals; Benzofurans; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Female; Male; Pentanols; Quinolines; Receptors, Glucocorticoid; Treatment Outcome; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha | 2017 |
Electroencephalographic olfactometry (EEGO) analysis of odour responses in dogs.
Topics: Animals; Cyclohexenes; Dog Diseases; Dogs; Electroencephalography; Limonene; Male; Odorants; Olfaction Disorders; Pentanols; Reference Values; Smell; Terpenes | 2000 |
[Immobilon-Revivon--a neuroleptanalgeticum and its antagonist in dogs (author's transl)].
Topics: Acepromazine; Analgesics; Animals; Castration; Cesarean Section; Cyclopropanes; Dog Diseases; Dogs; Drug Combinations; Evaluation Studies as Topic; Female; Male; Morphinans; Neoplasms; Neuroleptanalgesia; Pentanols; Pregnancy; Tooth Extraction; Wounds and Injuries | 1973 |